Neurocrine Biosciences, Inc.

NBIXRank #166 of 316

Reference Jun 30, 2026 close implied by Form 13F filings

Circulating market cap

$17.13B

Upper bound: lock-ups and restricted stock not reviewed yet.

Traditional market cap: $17.13B
Fully diluted value: $17.67B
Free float market cap: -
Gap to traditional: 0

Circulating supply101.65M / 101.65M

Free float
Locked team
Other restricted

Circulating: 101.65M · 100.0%
Free float: -
Locked team: n/r
Other restricted: n/r
Total outstanding: 101,649,181

Lock-ups and restricted stock for this company have not been reviewed yet. Only unlisted share classes are excluded, so circulating supply is an upper bound.

Supply breakdown

Shares as of Jul 22, 2026

Circulating100.0%101.65M shares

Category	Shares	%	Value	Status
Circulating	101.65M	100.0%	$17.13B	Estimated
Free float	-	-	-	Unavailable
Insider-held, unrestricted	-	-	-	Unavailable
Locked team funds	-	-	-	Unavailable
Other restricted (unlisted classes only)	-	-	-	Unavailable
Total outstanding	101.65M	100.0%	$17.13B	Verified
Ownership views (overlap the categories above, never added)
Institutional holdings (13F)	100.92M	99.3%	$17.01B	Estimated
Insider-held, all (Forms 3, 4, 5)	-	-	-	Unavailable

Institutional and insider holdings can include both tradable and locked shares, so they are shown for reference and never added to the total. Check: no class has more shares deducted than it has outstanding, and the review found no shares that may be counted twice: reconciles.

Valuation

Traditional$17.13B
Fully diluted$17.67B
Circulating$17.13B
Free float-
Locked team value$0
Other restricted value$0

Locked and restricted shares

Not reviewed yet.

Institutional holders

13F, quarter ended Jun 30, 2026

Holder	Shares	% of total
BlackRock, Inc.	13.71M	13.49%
JPMORGAN CHASE & CO	6.40M	6.29%
Dodge & Cox	5.58M	5.49%
VANGUARD PORTFOLIO MANAGEMENT LLC	4.97M	4.89%
VANGUARD CAPITAL MANAGEMENT LLC	4.55M	4.47%
STATE STREET CORP	4.39M	4.31%
AQR CAPITAL MANAGEMENT LLC	3.82M	3.76%
RENAISSANCE TECHNOLOGIES LLC	2.34M	2.30%
GEODE CAPITAL MANAGEMENT, LLC	2.14M	2.10%
TWO SIGMA INVESTMENTS, LP	2.08M	2.04%

Sum of long share positions in Form 13F reports for the quarter. 13F covers managers with over $100M in US equities; some positions are reported by more than one filer.

Insiders

Forms 3, 4 and 5

Form 4 aggregation pending

Share classes

Class	Listing	Shares outstanding	As of
Common stock	NBIX on Nasdaq	101,649,181	Jul 22, 2026

Notes and sources

NEUROCRINE BIOSCIENCES INC 10-Q for period ended 2026-06-30, Cover page (0000914475-26-000037)
SEC public float (non-affiliates): $9.52B as of Jun 30, 2025, from the 10-K cover. It is a dollar value at a past date, not circulating supply.